Pyelectasis And Kidney Health

  • Alessia ZappaIntegrated Masters, Biomedical Sciences, University of York, UK

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Pyelectasis is a foetal condition which commonly occurs during the second trimester, where an unborn baby has a buildup of urine inside the central part of one or both of their forming kidneys (known as the renal pelvis). In a normally-developing foetus, waste products circulating their body will filter out of the bloodstream and collect in the kidneys as urine. The urine then travels from the kidney to the bladder, through a tube called the ureter that connects the two organs. Once in the bladder, the urine is expelled into the amniotic sac. In a baby who develops pyelectasis, however, the urine builds up in the renal pelvis of their kidney(s) and does not leave, resulting in larger-than-normal kidneys. When the condition only affects one kidney, this is known as unilateral pyelectasis, whereas when the condition affects both kidneys, this is known as bilateral pyelectasis.1  

Although this sounds alarming, fortunately roughly 90% of all pyelectasis cases are mild and can resolve themselves over the course of the pregnancy.1 However, in 10% of cases, the significant and persistent swelling of the kidneys can lead to severe pyelectasis, known as antenatal hydronephrosis. These more severe cases do require medical attention as if left untreated, the condition could affect kidney health.2 It is very important to maintain kidney health as these organs help keep your body functioning properly - by removing waste products from the blood, by producing hormones, by controlling your blood pressure, and by maintaining healthy amounts of water, salts and minerals.

This article will detail the causes of pyelectasis, how severe pyelectasis can affect a foetus’ kidney health, and the diagnosis and treatment methods used to resolve the condition.   

Causes and risk factors of pyelectasis

There are two main causes of pyelectasis:

  • Ureteropelvic junction obstruction - One reason why pyelectasis occurs is when a blockage forms in the foetus’ ureter, preventing the urine from leaving the kidney and travelling to the bladder. This is called ureteropelvic junction obstruction. This blockage might form due to a narrowing of the ureter.3 
  • Vesicoureteral reflux - Another reason why pyelectasis occurs is when, instead of the urine travelling from the kidney down the ureter to the bladder, the opposite occurs. This flow back from the bladder to the kidneys happens when the ureterovesical junction (which is where the ureter meets the bladder) does not close properly, allowing for the urine to travel back up the tube.4 

Alongside these two main causes of pyelectasis, some genetic disorders are associated with an increased risk of developing the condition. The main example is Down’s syndrome - although most cases of pyelectasis are not associated with genetics if your foetus has Down syndrome, they are more likely to develop pyelectasis during the second trimester.5  

Is it possible to prevent pyelectasis from happening?

It is not possible to prevent pyelectasis from developing in a foetus, as it is a condition which usually occurs due to a random variation in the development of the baby.1 

The impact of pyelectasis on kidney health 

In 90% of all foetal pyelectasis cases, the enlargement of the renal pelvis is between 4 to 9 millimetres in diameter. These cases are referred to as mild pyelectasis and typically do not cause any noticeable symptoms in the foetus or the mother. This means mild pyelectasis has no significant impact on the foetus’ short-term or long-term health of its kidney. It is common in such cases for the build-up of urine in their kidneys to resolve itself by the third trimester.1  

In the other 10% of cases, the enlargement of the renal pelvis is greater than 10 millimetres, resulting in a balloon-shaped kidney which can persist throughout the entire pregnancy to after birth. This more severe type of pyelectasis is known as antenatal hydronephrosis. Unlike mild pyelectasis, antenatal hydronephrosis can affect kidney health if left untreated.5 Examples of how antenatal hydronephrosis can damage the foetus’ kidneys include the following:

  • A common complication of antenatal hydronephrosis is the development of a urinary tract infection (UTI), as the urine insider the renal pelvis makes them more susceptible to developing an infection. This UTI could in turn lead to pyelonephritis (infection of the kidney itself). If such kidney infection spreads to the rest of the baby’s organs via the bloodstream, then it can cause the serious issue of sepsis.
  • Antenatal hydronephrosis can lead to high blood pressure.
  • Antenatal hydronephrosis can result in scarring of kidney tissue due to the extreme enlargement of the renal pelvis.5

All the potential damage that can occur to the kidneys when a baby has antenatal hydronephrosis (listed above) can result in a significant decrease in healthy kidney function, which in turn can lead to kidney disease and sometimes even failure.5  

Hence, in order to prevent any damage to one’s kidney health, it is important to properly diagnose and treat severe pyelectasis. 

Management and treatment of pyelectasis

Diagnosis of pyelectasis

Due to the fact that most cases of pyelectasis lead to no observable symptoms in the foetus or the mother, the condition is typically found and diagnosed during routine ultrasound checkups during the second trimester of pregnancy (which is when the kidneys should be developed). Medical professionals will diagnose pyelectasis if they notice the enlargement of one or both of the kidneys during these ultrasound scans.6 

Monitoring of pyelectasis

Once a foetus is diagnosed with pyelectasis, medical professionals will monitor the condition throughout the remainder of the pregnancy via additional ultrasound scans, to assess whether the enlargement of the kidney worsens, stays the same, or resolves itself. With mild pyelectasis cases, by the third trimester, the kidneys have returned to their healthy size.6 

With more severe pyelectasis cases (antenatal hydronephrosis), alongside the additional ultrasound monitoring throughout the pregnancy, the baby will likely go through further tests during the few weeks after birth, to check if there are continuing problems. These include the following: 

  • Blood tests, blood pressure tests and urine tests to assess kidney function and investigate whether the kidney is infected or damaged. 
  • Ultrasound scans to visualise the baby’s kidney, to see whether the ballooning of the kidney has decreased.
  • A micturating cystourethrogram (MCUG) is a test where a clear special liquid called contrast is passed through a thin tube placed into the baby’s bladder, and then a series of X-ray pictures are taken. This allows visualisation of the urinary system, to see if urine is flowing properly into the bladder. 
  • A dimercaptosuccinic acid (DMSA) scan or MAG3 Renogram scan are test where special substances called isotopes are injected into the baby’s veins and are then absorbed into the kidneys. These isotopes will show up on devices called gamma cameras, which are used to take pictures of the baby’s kidneys. Using these scans will help medical professionals to investigate the structure and function of the kidneys.

Treatments for severe pyelectasis (antenatal hydronephrosis) 

In most babies with antenatal hydronephrosis, the condition will get better as they get older. If their post-birth scans do show continuing problems with their kidneys, then the main type of treatment given is antibiotics. By giving these babies antibiotics, it will reduce their risk of developing a UTI and damaging their kidney health. 

In very rare cases where the antenatal hydronephrosis is exceptionally severe and is caused by a ureteropelvic junction obstruction, then surgery can be done. The most common type of surgery which is performed is a pyeloplasty. This surgery effectively corrects the blockage found in the ureter, as the surgeon cuts out this blockage, allowing urine to then freely flow from the kidneys to the bladder.7  

Summary

Pyelectasis is the foetal condition that concerns the build-up of urine in the kidneys of the baby, leading to the swelling of the organ. It usually occurs during the second trimester of pregnancy, when the kidneys have developed. The most common causes of pyelectasis include a blockage in the ureter connecting the kidneys to the bladder, or vesicoureteral reflux (when urine backflows into the kidneys from the bladder). Although pyelectasis sounds serious, over 90% of cases resolve themselves spontaneously by the time the baby is born. However, in 10% of cases, this swelling of the kidneys due to urine build-up can persist, and this is called antenatal hydronephrosis. If such type of severe pyelectasis is left untreated, it can damage kidney health by increasing the baby’s blood pressure, scarring kidney tissue, and leading to infection. In order to prevent this, once diagnosed through a routine ultrasound scan during the second trimester of pregnancy, pyelectasis is monitored through additional scans throughout the rest of the pregnancy and the weeks after birth. If problems do persist after birth, babies can be given antibiotics to prevent any damage to their kidneys. In very rare cases, the surgery pyeloplasty can be done to correct any blockage found in the ureter to allow normal flow of urine and to protect kidney health.

References

  1. Chudleigh T. Mild pyelectasis. Prenat Diagn. 2001 Nov;21(11):936–41.
  2. Loardi C, Signorelli M, Gregorini M, Marella D, Torri F, Zambelloni CM, et al. Moderate and severe fetal pyelectasis: Correlation between prenatal aspects and postnatal outcome. J Neonatal Perinatal Med. 2020;13(1):91–6.
  3. Gupta A, Dhua A, Agarwala S, Bhatnagar V. Pelviureteric junction obstruction with crossing lower polar vessel: indicators of preoperative diagnosis. J Indian Assoc Pediatr Surg. 2018 [cited 2024 May 15];23(3):123–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042171/ 
  4. Williams G, Fletcher JT, Alexander SI, Craig JC. Vesicoureteral reflux. Journal of the American Society of Nephrology. 2008 May [cited 2024 May 15];19(5):847–62. Available from: https://journals.lww.com/00001751-200805000-00008 
  5. Thotakura R, Anjum F. Hydronephrosis and hydroureter. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 May 15]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK563217/ 
  6. Signorelli M, Cerri V, Taddei F, Groli C, Bianchi UA. Prenatal diagnosis and management of mild fetal pyelectasis: implications for neonatal outcome and follow-up. Eur J Obstet Gynecol Reprod Biol. 2005 Feb 1;118(2):154–9. 
  7. Zhang L, Liu C, Li Y, Sun C, Li X. Determination of the need for surgical intervention in infants diagnosed with fetal hydronephrosis in china. Med Sci Monit. 2016 Nov 6 [cited 2024 May 15];22:4210–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100838/ 

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Alessia Zappa

Integrated Masters, Biomedical Sciences, University of York

Alessia (bilingual in both English and Italian) has recently graduated from the University of York with a Master of Biomedical Science in Biomedical Sciences. Throughout her degree, she has had significant practice in a variety of written communication styles – from literature reviews, grant proposals, laboratory reports, to developing a series of science revision activities aimed for 12-13 year olds. She also has had extensive experience in collecting data, both within a laboratory setting (particularly in cell culture experiments) and online through survey-based projects. She has a particular passion for cancer research and immunology, with her final year project focusing on how the immune cell macrophage can be manipulated in order to target melanoma.

Leave a Reply

Your email address will not be published. Required fields are marked *

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right